ALAN AMC logo

ALAN AMC

Asia, Beijing, China, Beijing

Description

ALAN AMC is an asset management firm.

Investor Profile

ALAN AMC has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (75%)
  • Series A (25%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Battery
  • Energy
  • Energy Storage
  • Manufacturing
  • Biopharma
  • Pharmaceutical
  • Outsourcing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ALAN AMC frequently co-invest with?

XC
Asia, Beijing, China, Beijing
Co-Investments: 1
Binfu Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
October Capital
North America, Missouri, United States, Kansas City
Co-Investments: 2
BC
North America, New York, United States, Brooklyn
Co-Investments: 1
Co-Stone Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
CS Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Co-Investments: 1
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 2

What are some of recent deals done by ALAN AMC?

Biointron

Shanghai, Shanghai, China

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.

BiotechnologyHealth CareMedical
Series BAug 31, 2022
Amount Raised: $72,564,728
Baiying Bio

Beijing, Beijing, China

Baiying Bio is a research and development outsourcing service provider.

BiotechnologyOutsourcingService Industry
Series BAug 31, 2022
Amount Raised: $72,564,728
SVOLT

Changzhou, Zhejiang, China

SVOLT is an energy tech company that specializes in the manufacturing of automotive power batteries and energy storage systems.

BatteryEnergyEnergy StorageManufacturing
Series AMar 22, 2021
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJul 24, 2020
Amount Raised: $171,005,942